[PaulC]

Milos, there is no anti-activated protein C (anti-APC) drug on the on the market in any country. ApcinteX Ltd and Centessa Pharmaceuticals are testing (phase 1/2 clinical trial) an anti-APC drug called SerpinPC (clinical trial # NCT04073498), with results expected in October 2023. See press release here: https://investors.centessa.com/news-releases/news-release-details/centessa-pharmaceuticals-announces-positive-topline-data-proof